SOLICITATION NOTICE
65 -- The application of a pre-clinical assay for comparing Immune response to Cas proteins derived from different organism
- Notice Date
- 8/30/2022 11:18:14 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- FDA OFFICE OF OPERATIONS Silver Spring MD 20993 USA
- ZIP Code
- 20993
- Solicitation Number
- 75F40122R00087
- Response Due
- 9/12/2022 11:00:00 AM
- Archive Date
- 09/12/2022
- Point of Contact
- Natapol Sirikhan, Phone: 240-402-8031
- E-Mail Address
-
Natapol.Sirikhan@fda.hhs.gov
(Natapol.Sirikhan@fda.hhs.gov)
- Small Business Set-Aside
- SBA Total Small Business Set-Aside (FAR 19.5)
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 and 13.1 as supplemented with additional information in this notice. Quotes are being requested and this announcement constitutes the only solicitation. The Government contemplates issuing a firm fixed-price purchase order resulting from this solicitation. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2021-05 dated March 10, 2021. The associated North American Industrial Classification System (NAICS) code for this procurement is 541690 � Other Scientific and Technical Consulting Services, with an associated size standard of 1,000 employees. This requirement is being solicited as a total small business set-aside. This propose simplified acquisition combined synopsis/solicitation is for services; the Government is �soliciting only to after exclusion of sources. Interested parties may identify their interests and capabilities to respond to the requirement within seven (7) days after the publication of this notice. A determination by the Government not to reissue and recompete this proposed simplified acquisition based upon responses to this notice, is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct another competitive requirement. No further solicitation is available. FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by September 12, 2022, 2:00 PM EST.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/3257cd08100e4e99b4d06b1df4f575d3/view)
- Place of Performance
- Address: Silver Spring, MD 20903, USA
- Zip Code: 20903
- Country: USA
- Zip Code: 20903
- Record
- SN06446824-F 20220901/220830230129 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |